Currently, the scientific literature only reflects a few attempts to improve gut dysbiosis in CF, including the use of CFTR modulators (Ivacaftor), which are sown to increase the relative abundance of Akkermansia [17]. The gene discussed is CFTR; the disease is cystic fibrosis.